The National Pharmaceutical Pricing Authority has issued a notification fixing the retail price, exclusive of GST, of 71 key drug formulations. These include anti-cancer medicine Reliance Life Sciences' Trastuzumab (₹11,966 per vial), a suspension of mefenamic acid used to treat period pain (₹0.94/ml), among others. The list also includes anti-diabetic drug combinations, containing Empagliflozin.